Journals in Genetics

7 results in All results

Electronic Journal of Biotechnology

• ISSN: 0717-3458
• 5 Year impact factor: 2.5
• Impact factor: 2.3

Issues prior to 2014 are available here.Electronic Journal of Biotechnology is an international, scientific open access journal that publishes articles from all areas related to biotechnology.The journal provides an effective way to publish research, review articles, and short communications. Video material, animation sequences, and 3D are also accepted to support and enhance articles. The articles will be examined by a scientific committee and anonymous evaluators and published every two months (January 15, March 15, May 15, July 15, September 15, November 15).The following areas are covered in the journal: • Animal biotechnology • Environmental biotechnology • Food biotechnology • Marine biotechnology • Medical biotechnology • Microbial biotechnology • Molecular biology and genetics • Plant biotechnology • Process biotechnology

Subscribe

Genetics in Medicine

• ISSN: 1098-3600
• 5 Year impact factor: 7.4
• Impact factor: 6.6

Genetics in Medicine (GIM) is an official journal of the American College of Medical Genetics and Genomics. The journal's mission is to enhance the knowledge, understanding, and practice of medical genetics and genomics through publications in clinical and laboratory genetics and genomics, including ethical, legal, and social issues as well as public health. As genetics and genomics continue to increase in importance and relevance in medical practice, the journal will be an accessible and authoritative resource for the dissemination of medical genetic knowledge to all medical providers through appropriate original research, reviews, commentaries, standards, and guidelines. GIM encourages research that combats racism, includes diverse populations and is written by authors from diverse and underrepresented backgrounds.In addition:GIM does not publish case reportsManuscripts reporting population level research carried out in predominantly or exclusively White populations will generally not be accepted without strong justification for lack of diversity in the population studied.The significance of articles reporting data and/or observations from a limited geographic region is evaluated in the context of whether they are generalizable across relevant populations or whether they might fill a knowledge gap in populations that are underrepresented in genetics research or that experience health disparities.Although cancer genetics is a focus, GIM discourages cancer genetics manuscripts with data limited to somatic and/or tumor genetics. Manuscripts with novel findings on non-germline genetics (for example, somatic [tumor] variation, CHIP [clonal hematopoiesis of indeterminate potential], somatic and constitutional mosaicism) that inform our understanding of germline risk may also be considered. Manuscripts reporting on circulating tumor DNA (ctDNA) or "liquid biopsy" are also generally not within the scope of GIM.Manuscripts should not contain previously published material without appropriate permission.GWAS studies are generally low priority for GIM.

Subscribe

Global Medical Genetics

• ISSN: 2699-9404

The contents before Volume 11 of Global Medical Genetics published with Thieme can be found here (https://www.thieme-connect.com/products/ejournals/journal/10.1055/s-00046370). Global Medical Genetics is an international Open Access journal devoted to publishing peer-reviewed, high quality, original papers in the field of genetics. We publish the following article types: original research articles, reviews, editorials, letters, and conference reports.Global Medical Genetics welcomes papers on all topics of genetics, including:Genes involved in the pathology of human diseaseMolecular analysis of simple and complex genetic traitsCancer geneticsEpigeneticsGene therapyDevelopmental geneticsRegulation of gene expressionStrategies and technologies for extracting function from genomic dataPharmacological genomicsGenome evolutionOfficial Journal of Tianjin Key Laboratory of Gene Therapy for Blood Diseases, Chinese Academy of Medical Sciences Key Laboratory of Gene Therapy for Blood Diseases, Tianjin Society for Hematology and Regeneration Medicine and International Knowledge Direct Medical Association.We sincerely invite you to submit manuscripts to Global Medical Genetics. The Article Processing Charge is waived for accepted manuscripts.Abstracting and indexing:ESCI, PubMed, PubMed Central, DOAJ, EBSCO, ProQuestGMG requires that authors follow the ICMJE (International Committee of Medical Journal Editors) recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals. More information can be found here: https://www.icmje.orgEditorial Board

Subscribe

Heliyon

• ISSN: 2405-8440
• 5 Year impact factor: 3.9
• Impact factor: 3.4

Heliyon considers research from all areas of the physical, applied, life, social and medical sciences. We publish manuscripts reporting scientifically accurate and valuable research, which adheres to accepted ethical and scientific publishing standards. As such Heliyon publishes new insights as well as extensions on existing theories, negative/null results and replication studies.Submissions covering arts, humanities and law are not considered in Heliyon. Authors of these submissions are encouraged to submit directly to our partner journal Social Sciences & Humanities Open.Heliyon classifies manuscripts/articles into different sections based on the research topic discussed. Some sections exclude certain types of studies from their scope. To know more and to see the kind of manuscripts the various sections publish, please visit: https://www.cell.com/heliyon/sectionsA dedicated in-house editorial office team, internal editors as well as external academic section and associate editors handle your manuscript and manage the publication process, giving your research the editorial support and quality control it deserves.If it's important to you, it's important to us. Submit your paper today.

Subscribe

Innovative Practice in Breast Health

• ISSN: 2950-2128

The aim of Innovative Practice in Breast-Health is to provide a platform for the sharing of new knowledge and research related to evaluation of applications of new technologies in the field of breast diseases. The journal seeks to promote the development and understanding of the latest advances in artificial intelligence, data science and data omics, telemedicine, image-assisted surgery, connected objects and telemedicine, prediction, personalized medicine and simulation in the field of breast cancer and other breast pathologies.This journal will publish high quality peer-reviewed original research, review articles, editorials, case reports (proof of concept of innovative applications of artificial intelligence-related technologies), and perspectives that encompass the evaluation and application of innovative technologies in the treatment, prevention, diagnosis and management of breast pathologies.Innovative Practice in Breast-Health welcomes research from all relevant disciplines, provided that it involves artificial intelligence-related technologies and breast diseases, including but not limited to surgery, imaging, medical oncology, radiation oncology, pathology, genetics, epidemiology, public health, nursing and allied health sciences, psychology, sociology, education, economic and health policy and management.The scope of the journal includes but is not limited to:Clinical trials and translational research regarding artificial intelligence-related technologies and breast pathologiesArtificial intelligence and its application to data science, data omics, telemedicine and breast pathologiesAlgorithms for analyzing large-scale data sets for breast cancer diagnosis, prognosis and treatment; and also patient experience and patient-related outcomesMachine learning and deep learning approaches for breast imaging and surgeryTelemedicine and telehealth applications for the management and screening of breast cancer and breast diseasesBig data and data omics applications in breast cancer research, diagnosis and treatment

Subscribe

Ocular Genetics and Omics

• ISSN: 2949-7817

Ocular Genetics and Omics (OGO) , an international peer-reviewed open access journal, aims to provide a forum for highlighting new advances not only in clinical and experimental research in the diagnosis and treatment of ocular genetic diseases, but also investigation applying omics technology in clinical and laboratory samples of eye disorders. Original research, review, method protocol, short communications, letter, case reports and case series are welcome.OGO welcomes research to confirm novel causative genes, to verify the function of the variants in the progress, to elucidate the underlying molecular mechanisms, to develop novel treatment of ocular genetic disease. Clinical studies containing large pedigrees, demonstrating novel genotypes or phenotypes, presenting results of various interventions are also welcomed. In addition, investigations exploring the integrated biology of eye diseases by applying omics technologies, including genomics, transcriptomics, proteomics, metabolomics, glycomics, lipidomics and ligandomics, as well as other bioinformatics approaches are encouraged.Editorial Board

Subscribe

Rare

• ISSN: 2950-0087

The Official Journal of the Undiagnosed Diseases Network International.Rare. Open Research in Rare Diseases is an open-access, multidisciplinary, international journal that aims to have a clinical impact on rare disease patients. It publishes rigorously peer-reviewed articles on research that improves the well-being and quality of life of patients with rare diseases - diagnosed or undiagnosed - and their families. The journal has a broad scope, including but not limited to:-Direct clinical and psychosocial care: diagnosis, follow-up, treatment, therapeutic advances, clinical trials, quality of life-Increasing diagnostic yield and early diagnosis: implementation of new DNA techniques, provision of genetic tests and newborn screening-Pharmacology: development and regulation of orphan drugs-Application of technologies to diagnose or interpret genetic variants-Health economics and public policies: regulatory, reimbursement policies-Legal perspectives: data sharing, privacy issues-Ethics: primary prevention and family information-Patient contributions to research: late diagnosis (patient journey)-International collaborative projects, initiatives by associations and the rare disease community.The journal is open in every sense: patients are encouraged to contribute with their experiences and needs, as they are one of the pillars of medical research.Publication formats include full-length research articles, reviews, case reports, correspondence, short communications, and commentaries.

Subscribe